Rafael Alessandro Ferreira Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rafael Alessandro Ferreira Gomes has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Dário Celestino Sobral Filho
Universidade de Pernambuco
3 shared publications - Fabiano Cantarelli
Hospital Dom Helder Câmara, Cabo de Santo Agostinho, Brazil
2 shared publications - João Carlos Ferreira Leal
Faculdade de Medicina de São José do Rio Preto
2 shared publications - Marcela Vasconcelos Montenegro
University of Pernambuco, Recife, PE, Brazil
2 shared publications - Walter Jose Gomes
Postgraduate Program in Cardiology, Universidade Federal de São Paulo (UNIFESP), São Paulo 04024-000, SP, Brazil
2 shared publications Aluisio Roberto Andrade Macedo Jr.
Hospital Dom Helder Camara, Cabo de Santo Agostinho, PE - Brazil
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (35)
When Coronary Thrombosis Outpaces Technical Success
- 2 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (35)
Open AccessWhen Coronary Thrombosis Outpaces Technical Success
- Open Access
- 26 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (34)
Left Atrial Appendage Aneurysm
- 26 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (34)
Open AccessLeft Atrial Appendage Aneurysm
- Open Access
- 26 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (34)
When Resources Define Operability After Pulmonary Endarterectomy
- 26 August 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (34)
Open AccessWhen Resources Define Operability After Pulmonary Endarterectomy
- Open Access
- 6 May 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (18) , 108030
Beyond ST-Segment Elevation
- 6 May 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (18) , 108030
Open AccessBeyond ST-Segment Elevation
- Open Access
- 8 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (14) , 107179
When Anticoagulation Leaves its Mark
- 8 April 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (14) , 107179
Open AccessWhen Anticoagulation Leaves its Mark
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
A Cirurgia é o Meio e não o Desfecho: Seguimento Tardio da Cirurgia de Revascularização Miocárdica
A cirurgia de revascularização do miocárdio (CRM) permanece em posição de destaque no tratamento da doença arterial coronariana (DAC), sobretudo nos subgrupos de pacientes de maior risco, como doença de múltiplos vasos, disfunção ventricular esquerda, diabetes mellitus e carga isquêmica elevada, comprovada por décadas de evidências científicas e seus resultados consistentes em longo prazo. A DAC tem evolução progressiva, sistêmica e crônica, o que torna o seguimento em longo prazo, essencial para a interpretação dos resultados nas estratégias terapêuticas. Desta
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Open AccessA Cirurgia é o Meio e não o Desfecho: Seguimento Tardio da Cirurgia de Revascularização Miocárdica
A cirurgia de revascularização do miocárdio (CRM) permanece em posição de destaque no tratamento da doença arterial coronariana (DAC), sobretudo nos subgrupos de pacientes de maior risco, como doença de múltiplos vasos, disfunção ventricular esquerda, diabetes mellitus e carga isquêmica elevada, comprovada por décadas de evidências científicas e seus resultados consistentes em longo prazo. A DAC tem evolução progressiva, sistêmica e crônica, o que torna o seguimento em longo prazo, essencial para a interpretação dos resultados nas estratégias terapêuticas. Desta
- Open Access
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Surgery is the Means, Not the End: Late Follow-Up of Coronary Artery Bypass Graft Surgery
Coronary artery bypass grafting (CABG) remains a leading treatment for coronary artery disease (CAD), particularly in high-risk patient subgroups such as those with multivessel disease, left ventricular dysfunction, diabetes mellitus, and high ischemic burden, as evidenced by decades of scientific evidence and its consistent long-term results. Coronary artery disease (CAD) has a progressive, systemic, and chronic evolution, which makes long-term follow-up essential for interpreting the results in therapeutic strategies. Therefore, outcomes after coronary artery bypass grafting (CABG) cannot be limited
- 1 January 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (4)
Open AccessSurgery is the Means, Not the End: Late Follow-Up of Coronary Artery Bypass Graft Surgery
Coronary artery bypass grafting (CABG) remains a leading treatment for coronary artery disease (CAD), particularly in high-risk patient subgroups such as those with multivessel disease, left ventricular dysfunction, diabetes mellitus, and high ischemic burden, as evidenced by decades of scientific evidence and its consistent long-term results. Coronary artery disease (CAD) has a progressive, systemic, and chronic evolution, which makes long-term follow-up essential for interpreting the results in therapeutic strategies. Therefore, outcomes after coronary artery bypass grafting (CABG) cannot be limited
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2026 (1)
Left Ventricular Guidewire Pacing Is Associated With Lower Pacing Lead‐Related Cardiac Tamponade During Transfemoral TAVI: A Systematic Review and Meta‐Analysis
Background: Rapid pacing is required during transcatheter aortic valve implantation (TAVI) to facilitate valve deployment. Conventional right ventricular (RV) temporary pacing requires transvenous lead placement and has been associated with mechanical complications, including cardiac perforation. Left ventricular (LV) guidewire pacing has emerged as an alternative strategy that may avoid lead‐related injury. We performed a systematic review and meta‐analysis to compare clinical and procedural outcomes between LV guidewire pacing and RV temporary pacing during TAVI. Methods: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science were searched through February 15, 2026. Comparative studies evaluating LV guidewire pacing versus RV temporary pacing during TAVI were included. The primary endpoint was global cardiac tamponade. Prespecified mechanistic analyses evaluated pacing lead‐related and annular rupture‐related tamponade. Secondary endpoints included all‐cause mortality, cardiovascular mortality, major adverse cardiovascular events (MACE), stroke, major vascular complications, bleeding, permanent pacemaker implantation, and procedural metrics. Random‐effects meta‐analyses were performed using Mantel–Haenszel models. Results: Five studies (one randomized controlled trial and four observational cohorts) comprising 2840 patients (1910 LV and 930 RV) were included. Global cardiac tamponade occurred in 1.1% of LV patients and 2.5% of RV patients (OR 0.45; 95% CI 0.18–1.16; p = 0.08). In mechanistic analyses, pacing lead‐related tamponade was significantly reduced with LV pacing (OR 0.09; 95% CI 0.02–0.56; p = 0.03), whereas annular rupture‐related tamponade did not differ between strategies. The pooled absolute risk reduction for pacing lead‐related cardiac tamponade was approximately 1.2%, corresponding to an estimated number needed to treat of 83. A signal toward lower all‐cause mortality was observed in pooled analyses, largely driven by observational cohorts. Major vascular complications and bleeding showed nonsignificant trends favoring LV pacing. Permanent pacemaker implantation did not differ significantly between strategies. LV pacing was associated with shorter procedural duration (mean difference −5.83 min; 95% CI −7.08 to −4.58; p < 0.001). Conclusions: LV guidewire pacing during transfemoral TAVI was associated with a lower risk of pacing lead‐related cardiac tamponade and shorter procedural duration. This benefit appears to be mechanism‐specific and should not be extrapolated to annular rupture or other nonlead‐related causes of tamponade. Although LV guidewire pacing may simplify procedural workflow, its use should be individualized according to baseline conduction risk and the availability of rapid bailout pacing strategies.
- 1 January 2026
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2026 (1)
Open AccessLeft Ventricular Guidewire Pacing Is Associated With Lower Pacing Lead‐Related Cardiac Tamponade During Transfemoral TAVI: A Systematic Review and Meta‐Analysis
Background: Rapid pacing is required during transcatheter aortic valve implantation (TAVI) to facilitate valve deployment. Conventional right ventricular (RV) temporary pacing requires transvenous lead placement and has been associated with mechanical complications, including cardiac perforation. Left ventricular (LV) guidewire pacing has emerged as an alternative strategy that may avoid lead‐related injury. We performed a systematic review and meta‐analysis to compare clinical and procedural outcomes between LV guidewire pacing and RV temporary pacing during TAVI. Methods: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science were searched through February 15, 2026. Comparative studies evaluating LV guidewire pacing versus RV temporary pacing during TAVI were included. The primary endpoint was global cardiac tamponade. Prespecified mechanistic analyses evaluated pacing lead‐related and annular rupture‐related tamponade. Secondary endpoints included all‐cause mortality, cardiovascular mortality, major adverse cardiovascular events (MACE), stroke, major vascular complications, bleeding, permanent pacemaker implantation, and procedural metrics. Random‐effects meta‐analyses were performed using Mantel–Haenszel models. Results: Five studies (one randomized controlled trial and four observational cohorts) comprising 2840 patients (1910 LV and 930 RV) were included. Global cardiac tamponade occurred in 1.1% of LV patients and 2.5% of RV patients (OR 0.45; 95% CI 0.18–1.16; p = 0.08). In mechanistic analyses, pacing lead‐related tamponade was significantly reduced with LV pacing (OR 0.09; 95% CI 0.02–0.56; p = 0.03), whereas annular rupture‐related tamponade did not differ between strategies. The pooled absolute risk reduction for pacing lead‐related cardiac tamponade was approximately 1.2%, corresponding to an estimated number needed to treat of 83. A signal toward lower all‐cause mortality was observed in pooled analyses, largely driven by observational cohorts. Major vascular complications and bleeding showed nonsignificant trends favoring LV pacing. Permanent pacemaker implantation did not differ significantly between strategies. LV pacing was associated with shorter procedural duration (mean difference −5.83 min; 95% CI −7.08 to −4.58; p < 0.001). Conclusions: LV guidewire pacing during transfemoral TAVI was associated with a lower risk of pacing lead‐related cardiac tamponade and shorter procedural duration. This benefit appears to be mechanism‐specific and should not be extrapolated to annular rupture or other nonlead‐related causes of tamponade. Although LV guidewire pacing may simplify procedural workflow, its use should be individualized according to baseline conduction risk and the availability of rapid bailout pacing strategies.
- 7 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 171-172
Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy: Toward a Precision‐Guided Approach
- 7 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 171-172
Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy: Toward a Precision‐Guided Approach
- Open Access
- 22 July 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (9)
Revisiting Prinzmetal Legacy: The Structural Determinants of Coronary Spasm in Angina and Nonobstructive Coronary Arteries
- 22 July 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (9)
Open AccessRevisiting Prinzmetal Legacy: The Structural Determinants of Coronary Spasm in Angina and Nonobstructive Coronary Arteries